Novartis India Limited submitted a regulatory disclosure to BSE Limited regarding the outcome of its 246th meeting of the Board of Directors held on July 29, 2026.
The Board noted/approved the reconstitution of three key committees due to appointment and resignation of directors. The reconstitution was done in compliance with the requirements of the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Committee Reconstitution Details
Audit Committee:
- Ms. Suchita Sharma (Additional Director, independent category) - Chairperson
- Mr. Shashank Sinha (Additional Director, independent category) - Member
- Mr. Ramesh Ramadurai (Additional Director, independent category) - Member
- Ms. Jagriti Gupta (Additional Director, non-executive, non-independent category) - Member
Nomination and Remuneration Committee:
- Mr. Shashank Sinha (Additional Director, independent category) - Chairperson
- Mr. Ramesh Ramadurai (Additional Director, independent category) - Member
- Mr. Kshitij Sheth (Additional Director, non-executive, non-independent category) - Member
Corporate Social Responsibility Committee:
- Mr. Ashok Bhatia (Additional Director, non-executive, non-independent category) - Chairperson
- Mr. Ramesh Ramadurai (Additional Director, independent category) - Member
- Ms. Suchita Sharma (Additional Director, independent category) - Member
Meeting Details
The board meeting commenced at 05:50 PM and concluded at 06:10 PM on July 29, 2026, lasting 20 minutes.